

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.63844803 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.63844803 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.31843417 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.31843417 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.97679943 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.65017679 |
| 7 | tryptophan metabolic process (GO:0006568) | 5.53007537 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 5.45501738 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 5.45501738 |
| 10 | tryptophan catabolic process (GO:0006569) | 5.45501738 |
| 11 | cysteine metabolic process (GO:0006534) | 5.45473687 |
| 12 | kynurenine metabolic process (GO:0070189) | 5.30951247 |
| 13 | glyoxylate metabolic process (GO:0046487) | 5.30747313 |
| 14 | alpha-linolenic acid metabolic process (GO:0036109) | 5.09078499 |
| 15 | bile acid biosynthetic process (GO:0006699) | 5.07513283 |
| 16 | sulfur amino acid catabolic process (GO:0000098) | 5.05907849 |
| 17 | urea metabolic process (GO:0019627) | 4.98589119 |
| 18 | urea cycle (GO:0000050) | 4.98589119 |
| 19 | high-density lipoprotein particle remodeling (GO:0034375) | 4.93811239 |
| 20 | protein carboxylation (GO:0018214) | 4.89936141 |
| 21 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.89936141 |
| 22 | tyrosine metabolic process (GO:0006570) | 4.82222119 |
| 23 | negative regulation of fibrinolysis (GO:0051918) | 4.80500084 |
| 24 | complement activation, alternative pathway (GO:0006957) | 4.68431729 |
| 25 | lysine metabolic process (GO:0006553) | 4.64006926 |
| 26 | lysine catabolic process (GO:0006554) | 4.64006926 |
| 27 | regulation of fibrinolysis (GO:0051917) | 4.62713803 |
| 28 | serine family amino acid catabolic process (GO:0009071) | 4.60877021 |
| 29 | regulation of protein activation cascade (GO:2000257) | 4.60735430 |
| 30 | homocysteine metabolic process (GO:0050667) | 4.58445054 |
| 31 | regulation of cholesterol esterification (GO:0010872) | 4.56875416 |
| 32 | nitrogen cycle metabolic process (GO:0071941) | 4.55190079 |
| 33 | aromatic amino acid family metabolic process (GO:0009072) | 4.53580048 |
| 34 | reverse cholesterol transport (GO:0043691) | 4.50626512 |
| 35 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.48239574 |
| 36 | Golgi transport vesicle coating (GO:0048200) | 4.48015061 |
| 37 | COPI coating of Golgi vesicle (GO:0048205) | 4.48015061 |
| 38 | epoxygenase P450 pathway (GO:0019373) | 4.37398610 |
| 39 | regulation of triglyceride catabolic process (GO:0010896) | 4.35886302 |
| 40 | plasma lipoprotein particle remodeling (GO:0034369) | 4.34501356 |
| 41 | protein-lipid complex remodeling (GO:0034368) | 4.34501356 |
| 42 | macromolecular complex remodeling (GO:0034367) | 4.34501356 |
| 43 | bile acid metabolic process (GO:0008206) | 4.33245362 |
| 44 | regulation of complement activation (GO:0030449) | 4.33085838 |
| 45 | amino-acid betaine metabolic process (GO:0006577) | 4.28292642 |
| 46 | cellular glucuronidation (GO:0052695) | 4.23137272 |
| 47 | phospholipid efflux (GO:0033700) | 4.21655980 |
| 48 | indolalkylamine metabolic process (GO:0006586) | 4.18076526 |
| 49 | negative regulation of cholesterol transport (GO:0032375) | 4.10141922 |
| 50 | negative regulation of sterol transport (GO:0032372) | 4.10141922 |
| 51 | aldehyde catabolic process (GO:0046185) | 4.10002786 |
| 52 | plasma lipoprotein particle clearance (GO:0034381) | 4.09159156 |
| 53 | bile acid and bile salt transport (GO:0015721) | 4.08886486 |
| 54 | primary alcohol catabolic process (GO:0034310) | 4.08072067 |
| 55 | benzene-containing compound metabolic process (GO:0042537) | 4.06737949 |
| 56 | exogenous drug catabolic process (GO:0042738) | 4.05153523 |
| 57 | alpha-amino acid catabolic process (GO:1901606) | 4.01730868 |
| 58 | triglyceride homeostasis (GO:0070328) | 4.01338764 |
| 59 | acylglycerol homeostasis (GO:0055090) | 4.01338764 |
| 60 | glucuronate metabolic process (GO:0019585) | 3.97233299 |
| 61 | uronic acid metabolic process (GO:0006063) | 3.97233299 |
| 62 | ethanol oxidation (GO:0006069) | 3.96958015 |
| 63 | L-serine metabolic process (GO:0006563) | 3.92714778 |
| 64 | cholesterol efflux (GO:0033344) | 3.92660617 |
| 65 | response to nitrosative stress (GO:0051409) | 3.87352540 |
| 66 | drug catabolic process (GO:0042737) | 3.85700673 |
| 67 | serine family amino acid metabolic process (GO:0009069) | 3.84663149 |
| 68 | omega-hydroxylase P450 pathway (GO:0097267) | 3.83651476 |
| 69 | cellular biogenic amine catabolic process (GO:0042402) | 3.79685730 |
| 70 | amine catabolic process (GO:0009310) | 3.79685730 |
| 71 | urate metabolic process (GO:0046415) | 3.74021775 |
| 72 | cellular ketone body metabolic process (GO:0046950) | 3.73108192 |
| 73 | cellular amino acid catabolic process (GO:0009063) | 3.73036950 |
| 74 | cellular modified amino acid catabolic process (GO:0042219) | 3.72779809 |
| 75 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.71565786 |
| 76 | fibrinolysis (GO:0042730) | 3.70286038 |
| 77 | glycine metabolic process (GO:0006544) | 3.69788548 |
| 78 | plasma lipoprotein particle assembly (GO:0034377) | 3.68556319 |
| 79 | low-density lipoprotein particle remodeling (GO:0034374) | 3.67987043 |
| 80 | iron ion import (GO:0097286) | 3.67361344 |
| 81 | intestinal cholesterol absorption (GO:0030299) | 3.66004666 |
| 82 | arginine metabolic process (GO:0006525) | 3.65390744 |
| 83 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.64739223 |
| 84 | phospholipid homeostasis (GO:0055091) | 3.64504836 |
| 85 | ethanol metabolic process (GO:0006067) | 3.59707664 |
| 86 | glutamate metabolic process (GO:0006536) | 3.59249357 |
| 87 | L-ascorbic acid metabolic process (GO:0019852) | 3.55178845 |
| 88 | coenzyme catabolic process (GO:0009109) | 3.53438611 |
| 89 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.53374689 |
| 90 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.53374689 |
| 91 | serine family amino acid biosynthetic process (GO:0009070) | 3.51149438 |
| 92 | flavonoid metabolic process (GO:0009812) | 3.49184369 |
| 93 | cholesterol homeostasis (GO:0042632) | 3.48947451 |
| 94 | drug transmembrane transport (GO:0006855) | 3.48724082 |
| 95 | regulation of cholesterol homeostasis (GO:2000188) | 3.48364350 |
| 96 | regulation of bile acid biosynthetic process (GO:0070857) | 3.47494613 |
| 97 | imidazole-containing compound metabolic process (GO:0052803) | 3.46711540 |
| 98 | sterol homeostasis (GO:0055092) | 3.45580644 |
| 99 | short-chain fatty acid metabolic process (GO:0046459) | 3.44193024 |
| 100 | lipoprotein metabolic process (GO:0042157) | 3.42720097 |
| 101 | xenobiotic catabolic process (GO:0042178) | 3.42127964 |
| 102 | positive regulation of lipid catabolic process (GO:0050996) | 3.41368342 |
| 103 | plasma lipoprotein particle organization (GO:0071827) | 3.40474470 |
| 104 | heme transport (GO:0015886) | 3.35008694 |
| 105 | cofactor catabolic process (GO:0051187) | 3.34684102 |
| 106 | COPII vesicle coating (GO:0048208) | 3.33657110 |
| 107 | carboxylic acid catabolic process (GO:0046395) | 3.33463770 |
| 108 | organic acid catabolic process (GO:0016054) | 3.33463770 |
| 109 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.31326455 |
| 110 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.30821150 |
| 111 | oligosaccharide catabolic process (GO:0009313) | 3.28204019 |
| 112 | protein-lipid complex assembly (GO:0065005) | 3.27678143 |
| 113 | acute-phase response (GO:0006953) | 3.26778983 |
| 114 | glycosphingolipid catabolic process (GO:0046479) | 3.25410007 |
| 115 | ketone body metabolic process (GO:1902224) | 3.24170299 |
| 116 | negative regulation of protein activation cascade (GO:2000258) | 3.21103556 |
| 117 | negative regulation of lipase activity (GO:0060192) | 3.16477329 |
| 118 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.11139570 |
| 119 | drug metabolic process (GO:0017144) | 3.10516507 |
| 120 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.05555020 |
| 121 | intestinal absorption (GO:0050892) | 3.02073568 |
| 122 | negative regulation of coagulation (GO:0050819) | 2.98219525 |
| 123 | regulation of apoptotic cell clearance (GO:2000425) | 2.97507386 |
| 124 | glycolipid catabolic process (GO:0019377) | 2.97341862 |
| 125 | negative regulation of blood coagulation (GO:0030195) | 2.94497147 |
| 126 | negative regulation of hemostasis (GO:1900047) | 2.94497147 |
| 127 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.94473396 |
| 128 | vitamin transmembrane transport (GO:0035461) | 2.92108008 |
| 129 | protein-lipid complex subunit organization (GO:0071825) | 2.91606700 |
| 130 | proline metabolic process (GO:0006560) | 2.89232323 |
| 131 | gap junction assembly (GO:0016264) | 2.88967851 |
| 132 | vitamin biosynthetic process (GO:0009110) | 2.88872293 |
| 133 | cellular aldehyde metabolic process (GO:0006081) | 2.82079972 |
| 134 | midgut development (GO:0007494) | 2.78295246 |
| 135 | negative regulation of complement activation (GO:0045916) | 2.75364326 |
| 136 | primary alcohol metabolic process (GO:0034308) | 2.74461334 |
| 137 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.72023321 |
| 138 | negative regulation of wound healing (GO:0061045) | 2.71588371 |
| 139 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.67926947 |
| 140 | apoptotic cell clearance (GO:0043277) | 2.66534273 |
| 141 | regulation of plasminogen activation (GO:0010755) | 2.66296916 |
| 142 | proline biosynthetic process (GO:0006561) | 2.66126958 |
| 143 | ceramide catabolic process (GO:0046514) | 2.65513142 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.32075994 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.48036638 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.00119252 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.76801660 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.97281066 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.74178855 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.38326203 |
| 8 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.49704546 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.44820680 |
| 10 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.37314911 |
| 11 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.57407091 |
| 12 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.55652556 |
| 13 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.49713564 |
| 14 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.45605886 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.37002867 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.20741869 |
| 17 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 2.20062452 |
| 18 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.01247233 |
| 19 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.5476567 |
| 20 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.90410668 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.88537780 |
| 22 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.81244016 |
| 23 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.79866261 |
| 24 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.77732179 |
| 25 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.60429905 |
| 26 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.59170984 |
| 27 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.59112282 |
| 28 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.55566197 |
| 29 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.55260620 |
| 30 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.53494114 |
| 31 | GATA1_22025678_ChIP-Seq_K562_Human | 1.53255627 |
| 32 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.52296599 |
| 33 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.52282142 |
| 34 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.51834598 |
| 35 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.47413509 |
| 36 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.47282665 |
| 37 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.47200604 |
| 38 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.44710790 |
| 39 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.44540849 |
| 40 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.43170840 |
| 41 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.39697889 |
| 42 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.38717686 |
| 43 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.38715978 |
| 44 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.37356414 |
| 45 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.35530098 |
| 46 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.35382048 |
| 47 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.34826874 |
| 48 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.33350355 |
| 49 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.31788754 |
| 50 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.31466293 |
| 51 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.29646752 |
| 52 | * SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.27016401 |
| 53 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.25616621 |
| 54 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.22423490 |
| 55 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.22347411 |
| 56 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.20484069 |
| 57 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.19734212 |
| 58 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.18751859 |
| 59 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.18221004 |
| 60 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.16513955 |
| 61 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.13208180 |
| 62 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.13167816 |
| 63 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.12125480 |
| 64 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.10368221 |
| 65 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.09412456 |
| 66 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.08204717 |
| 67 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.05490439 |
| 68 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.03478857 |
| 69 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.03442094 |
| 70 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.02758895 |
| 71 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.01878520 |
| 72 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.01001891 |
| 73 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.00032371 |
| 74 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.00032371 |
| 75 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.95894635 |
| 76 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.94629712 |
| 77 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.93609493 |
| 78 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.92295328 |
| 79 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.91515330 |
| 80 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.90600090 |
| 81 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.89915850 |
| 82 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.89756470 |
| 83 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.89684837 |
| 84 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.89479108 |
| 85 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.88917202 |
| 86 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.88540190 |
| 87 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.88444754 |
| 88 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.88355022 |
| 89 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.88058636 |
| 90 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.87474024 |
| 91 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.87125756 |
| 92 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.86143782 |
| 93 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.86118313 |
| 94 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.85906046 |
| 95 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.85569319 |
| 96 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.85470717 |
| 97 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.84893140 |
| 98 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.84801969 |
| 99 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.84407249 |
| 100 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.83929887 |
| 101 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.83868526 |
| 102 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.83027896 |
| 103 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.82855009 |
| 104 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.82855009 |
| 105 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82852960 |
| 106 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.81622055 |
| 107 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81117050 |
| 108 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.80061222 |
| 109 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.79968909 |
| 110 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.78847242 |
| 111 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.78462788 |
| 112 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.78238782 |
| 113 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.76055050 |
| 114 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.76055050 |
| 115 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.76055050 |
| 116 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.75951225 |
| 117 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.75783423 |
| 118 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.70218996 |
| 119 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.69395539 |
| 120 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.67479275 |
| 121 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.66829233 |
| 122 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.65055147 |
| 123 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.64762418 |
| 124 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.63568049 |
| 125 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.62325538 |
| 126 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.62165745 |
| 127 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.62001237 |
| 128 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.61266480 |
| 129 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.59123787 |
| 130 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.58960275 |
| 131 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.58299283 |
| 132 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.57435606 |
| 133 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.57226683 |
| 134 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.57133183 |
| 135 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.56748062 |
| 136 | GATA1_19941826_ChIP-Seq_K562_Human | 0.56646131 |
| 137 | GATA2_19941826_ChIP-Seq_K562_Human | 0.56447950 |
| 138 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.56104046 |
| 139 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.55697028 |
| 140 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.55361626 |
| 141 | * HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.55084921 |
| 142 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.53899989 |
| 143 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.52889166 |
| 144 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.52528522 |
| 145 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.51611368 |
| 146 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.51501346 |
| 147 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.50188316 |
| 148 | AR_20517297_ChIP-Seq_VCAP_Human | 0.50019317 |
| 149 | ATF3_27146783_Chip-Seq_COLON_Human | 0.49560322 |
| 150 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.48701843 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.23486471 |
| 2 | MP0005360_urolithiasis | 7.02559412 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.78196852 |
| 4 | MP0005365_abnormal_bile_salt | 5.14360608 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.67125004 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.73413984 |
| 7 | MP0003252_abnormal_bile_duct | 3.47049736 |
| 8 | MP0009840_abnormal_foam_cell | 3.15393012 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.13478857 |
| 10 | MP0003941_abnormal_skin_development | 3.12631323 |
| 11 | MP0005083_abnormal_biliary_tract | 2.97111652 |
| 12 | MP0005332_abnormal_amino_acid | 2.66023189 |
| 13 | MP0003195_calcinosis | 2.65898360 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.60677120 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.36675581 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.14713371 |
| 17 | * MP0000609_abnormal_liver_physiology | 1.95663590 |
| 18 | MP0003186_abnormal_redox_activity | 1.85668920 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 1.84756017 |
| 20 | MP0005257_abnormal_intraocular_pressure | 1.82379181 |
| 21 | MP0003950_abnormal_plasma_membrane | 1.80966620 |
| 22 | MP0002118_abnormal_lipid_homeostasis | 1.79085866 |
| 23 | MP0010352_gastrointestinal_tract_polyps | 1.78290132 |
| 24 | MP0005319_abnormal_enzyme/_coenzyme | 1.75597285 |
| 25 | MP0003890_abnormal_embryonic-extraembry | 1.65307761 |
| 26 | MP0009697_abnormal_copulation | 1.64057375 |
| 27 | MP0003705_abnormal_hypodermis_morpholog | 1.59245740 |
| 28 | MP0009643_abnormal_urine_homeostasis | 1.59122339 |
| 29 | MP0003566_abnormal_cell_adhesion | 1.55506381 |
| 30 | MP0006054_spinal_hemorrhage | 1.53534007 |
| 31 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.40530073 |
| 32 | MP0001764_abnormal_homeostasis | 1.40329621 |
| 33 | MP0004957_abnormal_blastocyst_morpholog | 1.40193859 |
| 34 | MP0009764_decreased_sensitivity_to | 1.38054407 |
| 35 | MP0003868_abnormal_feces_composition | 1.36866711 |
| 36 | MP0003656_abnormal_erythrocyte_physiolo | 1.33167146 |
| 37 | MP0003136_yellow_coat_color | 1.30512921 |
| 38 | MP0002877_abnormal_melanocyte_morpholog | 1.29732221 |
| 39 | MP0003693_abnormal_embryo_hatching | 1.27886068 |
| 40 | MP0003011_delayed_dark_adaptation | 1.24788800 |
| 41 | MP0002090_abnormal_vision | 1.19583100 |
| 42 | MP0000598_abnormal_liver_morphology | 1.16916912 |
| 43 | MP0003436_decreased_susceptibility_to | 1.16856124 |
| 44 | * MP0004272_abnormal_basement_membrane | 1.15203855 |
| 45 | MP0005451_abnormal_body_composition | 1.14286761 |
| 46 | MP0002822_catalepsy | 1.10901644 |
| 47 | MP0010368_abnormal_lymphatic_system | 1.08850719 |
| 48 | MP0001756_abnormal_urination | 1.08104914 |
| 49 | MP0002938_white_spotting | 1.05123368 |
| 50 | MP0010678_abnormal_skin_adnexa | 1.04691232 |
| 51 | MP0005501_abnormal_skin_physiology | 1.04634974 |
| 52 | MP0008469_abnormal_protein_level | 1.04595054 |
| 53 | * MP0005408_hypopigmentation | 1.04298272 |
| 54 | MP0008007_abnormal_cellular_replicative | 1.03850328 |
| 55 | * MP0005636_abnormal_mineral_homeostasis | 1.03026915 |
| 56 | MP0003724_increased_susceptibility_to | 1.02561461 |
| 57 | MP0001915_intracranial_hemorrhage | 1.00065081 |
| 58 | MP0009763_increased_sensitivity_to | 0.98862656 |
| 59 | MP0005167_abnormal_blood-brain_barrier | 0.97908470 |
| 60 | MP0000647_abnormal_sebaceous_gland | 0.97741760 |
| 61 | MP0004233_abnormal_muscle_weight | 0.96486944 |
| 62 | MP0002254_reproductive_system_inflammat | 0.95856260 |
| 63 | MP0000604_amyloidosis | 0.93929989 |
| 64 | MP0009053_abnormal_anal_canal | 0.91827993 |
| 65 | MP0004782_abnormal_surfactant_physiolog | 0.90439895 |
| 66 | MP0003172_abnormal_lysosome_physiology | 0.89390466 |
| 67 | MP0005647_abnormal_sex_gland | 0.88812334 |
| 68 | MP0005197_abnormal_uvea_morphology | 0.86121428 |
| 69 | MP0008932_abnormal_embryonic_tissue | 0.85859868 |
| 70 | MP0001324_abnormal_eye_pigmentation | 0.83737351 |
| 71 | * MP0009642_abnormal_blood_homeostasis | 0.83366667 |
| 72 | MP0005220_abnormal_exocrine_pancreas | 0.83053285 |
| 73 | MP0003300_gastrointestinal_ulcer | 0.82688008 |
| 74 | MP0002136_abnormal_kidney_physiology | 0.81562602 |
| 75 | MP0005084_abnormal_gallbladder_morpholo | 0.81494243 |
| 76 | MP0001216_abnormal_epidermal_layer | 0.81482075 |
| 77 | MP0005275_abnormal_skin_tensile | 0.80250105 |
| 78 | MP0001730_embryonic_growth_arrest | 0.80167700 |
| 79 | MP0005058_abnormal_lysosome_morphology | 0.78046002 |
| 80 | MP0002060_abnormal_skin_morphology | 0.78044964 |
| 81 | MP0010307_abnormal_tumor_latency | 0.77069080 |
| 82 | MP0005376_homeostasis/metabolism_phenot | 0.75612160 |
| 83 | MP0002896_abnormal_bone_mineralization | 0.74972019 |
| 84 | MP0003111_abnormal_nucleus_morphology | 0.74442470 |
| 85 | MP0009672_abnormal_birth_weight | 0.74389025 |
| 86 | MP0001661_extended_life_span | 0.72891332 |
| 87 | MP0009384_cardiac_valve_regurgitation | 0.72676978 |
| 88 | MP0005670_abnormal_white_adipose | 0.72113237 |
| 89 | MP0005248_abnormal_Harderian_gland | 0.71557057 |
| 90 | MP0000383_abnormal_hair_follicle | 0.70207122 |
| 91 | MP0000377_abnormal_hair_follicle | 0.69633410 |
| 92 | MP0008438_abnormal_cutaneous_collagen | 0.67869996 |
| 93 | MP0001672_abnormal_embryogenesis/_devel | 0.66420432 |
| 94 | MP0005380_embryogenesis_phenotype | 0.66420432 |
| 95 | MP0005171_absent_coat_pigmentation | 0.66030076 |
| 96 | MP0002697_abnormal_eye_size | 0.63744272 |
| 97 | MP0002282_abnormal_trachea_morphology | 0.63412675 |
| 98 | MP0003984_embryonic_growth_retardation | 0.63251555 |
| 99 | MP0004883_abnormal_blood_vessel | 0.62998305 |
| 100 | MP0002295_abnormal_pulmonary_circulatio | 0.62502335 |
| 101 | MP0000371_diluted_coat_color | 0.62114747 |
| 102 | MP0003937_abnormal_limbs/digits/tail_de | 0.62108266 |
| 103 | MP0000358_abnormal_cell_content/ | 0.61437977 |
| 104 | MP0002088_abnormal_embryonic_growth/wei | 0.61393884 |
| 105 | MP0005464_abnormal_platelet_physiology | 0.61314856 |
| 106 | MP0004147_increased_porphyrin_level | 0.61215407 |
| 107 | * MP0002086_abnormal_extraembryonic_tissu | 0.60120809 |
| 108 | MP0009765_abnormal_xenobiotic_induced | 0.59999270 |
| 109 | MP0001849_ear_inflammation | 0.59185974 |
| 110 | MP0001533_abnormal_skeleton_physiology | 0.59054255 |
| 111 | MP0000249_abnormal_blood_vessel | 0.58731881 |
| 112 | MP0004264_abnormal_extraembryonic_tissu | 0.58679802 |
| 113 | MP0003448_altered_tumor_morphology | 0.58664336 |
| 114 | MP0005395_other_phenotype | 0.58660724 |
| 115 | MP0000538_abnormal_urinary_bladder | 0.58379209 |
| 116 | MP0003690_abnormal_glial_cell | 0.58167533 |
| 117 | * MP0002098_abnormal_vibrissa_morphology | 0.58000000 |
| 118 | MP0006082_CNS_inflammation | 0.57669362 |
| 119 | MP0005166_decreased_susceptibility_to | 0.57538662 |
| 120 | MP0008004_abnormal_stomach_pH | 0.57514772 |
| 121 | MP0010234_abnormal_vibrissa_follicle | 0.57299008 |
| 122 | MP0002078_abnormal_glucose_homeostasis | 0.56822174 |
| 123 | MP0002132_abnormal_respiratory_system | 0.56288894 |
| 124 | MP0005266_abnormal_metabolism | 0.55595332 |
| 125 | MP0005164_abnormal_response_to | 0.55410250 |
| 126 | MP0001881_abnormal_mammary_gland | 0.54967830 |
| 127 | MP0005023_abnormal_wound_healing | 0.54720012 |
| 128 | MP0005334_abnormal_fat_pad | 0.54369402 |
| 129 | MP0001845_abnormal_inflammatory_respons | 0.54168617 |
| 130 | MP0002971_abnormal_brown_adipose | 0.53891137 |
| 131 | MP0009785_altered_susceptibility_to | 0.53076878 |
| 132 | MP0002796_impaired_skin_barrier | 0.52384666 |
| 133 | MP0003638_abnormal_response/metabolism_ | 0.51944415 |
| 134 | MP0004947_skin_inflammation | 0.51100034 |
| 135 | MP0004043_abnormal_pH_regulation | 0.50391291 |
| 136 | MP0002876_abnormal_thyroid_physiology | 0.50070526 |
| 137 | MP0002168_other_aberrant_phenotype | 0.49825890 |
| 138 | MP0005666_abnormal_adipose_tissue | 0.49235671 |
| 139 | MP0002419_abnormal_innate_immunity | 0.49202755 |
| 140 | MP0006036_abnormal_mitochondrial_physio | 0.48938704 |
| 141 | MP0003279_aneurysm | 0.48762740 |
| 142 | MP0003453_abnormal_keratinocyte_physiol | 0.45755653 |
| 143 | MP0005535_abnormal_body_temperature | 0.45700468 |
| 144 | MP0003718_maternal_effect | 0.44877680 |
| 145 | MP0000639_abnormal_adrenal_gland | 0.44653708 |
| 146 | MP0001853_heart_inflammation | 0.43820323 |
| 147 | MP0002277_abnormal_respiratory_mucosa | 0.43724239 |
| 148 | MP0008873_increased_physiological_sensi | 0.43409782 |
| 149 | MP0005448_abnormal_energy_balance | 0.41663822 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.48625526 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.42842500 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.36022298 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.27089204 |
| 5 | Xanthomatosis (HP:0000991) | 5.59944478 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.46659142 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.45779102 |
| 8 | Complement deficiency (HP:0004431) | 4.83276524 |
| 9 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.56834210 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 4.41688251 |
| 11 | Joint hemorrhage (HP:0005261) | 4.29857881 |
| 12 | Abnormality of the common coagulation pathway (HP:0010990) | 4.23969991 |
| 13 | Hypolipoproteinemia (HP:0010981) | 4.20225825 |
| 14 | Fat malabsorption (HP:0002630) | 4.09915359 |
| 15 | Hyperammonemia (HP:0001987) | 4.05161624 |
| 16 | Hyperglycinuria (HP:0003108) | 3.97333537 |
| 17 | Epidermoid cyst (HP:0200040) | 3.83049922 |
| 18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.81940933 |
| 19 | Hyperglycinemia (HP:0002154) | 3.79052330 |
| 20 | Ketosis (HP:0001946) | 3.79024775 |
| 21 | Conjugated hyperbilirubinemia (HP:0002908) | 3.77709512 |
| 22 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.75701505 |
| 23 | Hypoglycemic coma (HP:0001325) | 3.74131276 |
| 24 | Hypoalphalipoproteinemia (HP:0003233) | 3.72385149 |
| 25 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.66444941 |
| 26 | Abnormality of glycine metabolism (HP:0010895) | 3.66444941 |
| 27 | Vacuolated lymphocytes (HP:0001922) | 3.65186046 |
| 28 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.64703987 |
| 29 | Abnormality of complement system (HP:0005339) | 3.61574666 |
| 30 | Abnormality of glycolipid metabolism (HP:0010969) | 3.56617259 |
| 31 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.56617259 |
| 32 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.56617259 |
| 33 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.54825147 |
| 34 | Abnormality of the intrinsic pathway (HP:0010989) | 3.46139474 |
| 35 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.34484111 |
| 36 | Abnormality of nucleobase metabolism (HP:0010932) | 3.30452318 |
| 37 | Hypercholesterolemia (HP:0003124) | 3.29994217 |
| 38 | Vascular calcification (HP:0004934) | 3.26106830 |
| 39 | Abnormality of methionine metabolism (HP:0010901) | 3.22099365 |
| 40 | Steatorrhea (HP:0002570) | 3.20999593 |
| 41 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.17891644 |
| 42 | Systemic lupus erythematosus (HP:0002725) | 3.17758351 |
| 43 | Abnormality of purine metabolism (HP:0004352) | 3.13326484 |
| 44 | Hepatocellular carcinoma (HP:0001402) | 3.04507266 |
| 45 | Abnormality of glycolysis (HP:0004366) | 3.04246365 |
| 46 | Increased serum pyruvate (HP:0003542) | 3.00465825 |
| 47 | Gout (HP:0001997) | 2.98392413 |
| 48 | Rhinitis (HP:0012384) | 2.96193016 |
| 49 | Cardiovascular calcification (HP:0011915) | 2.95402985 |
| 50 | Myocardial infarction (HP:0001658) | 2.94180292 |
| 51 | Ketoacidosis (HP:0001993) | 2.91047447 |
| 52 | Hyperbilirubinemia (HP:0002904) | 2.88945055 |
| 53 | Metabolic acidosis (HP:0001942) | 2.83222343 |
| 54 | Delayed CNS myelination (HP:0002188) | 2.80517375 |
| 55 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.80289288 |
| 56 | Spastic diplegia (HP:0001264) | 2.79122665 |
| 57 | Chronic bronchitis (HP:0004469) | 2.77000235 |
| 58 | Esophageal varix (HP:0002040) | 2.70842631 |
| 59 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.66060914 |
| 60 | Glomerulonephritis (HP:0000099) | 2.62861905 |
| 61 | Abnormal gallbladder physiology (HP:0012438) | 2.62460963 |
| 62 | Cholecystitis (HP:0001082) | 2.62460963 |
| 63 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.55436399 |
| 64 | Hydroxyprolinuria (HP:0003080) | 2.51212570 |
| 65 | Abnormality of proline metabolism (HP:0010907) | 2.51212570 |
| 66 | Malnutrition (HP:0004395) | 2.50521741 |
| 67 | Generalized aminoaciduria (HP:0002909) | 2.49490301 |
| 68 | Skin nodule (HP:0200036) | 2.45732420 |
| 69 | Lethargy (HP:0001254) | 2.39236092 |
| 70 | Multiple enchondromatosis (HP:0005701) | 2.38977087 |
| 71 | Irritability (HP:0000737) | 2.38041292 |
| 72 | Spontaneous abortion (HP:0005268) | 2.37281631 |
| 73 | Renal tubular acidosis (HP:0001947) | 2.37020048 |
| 74 | Increased cerebral lipofuscin (HP:0011813) | 2.35388216 |
| 75 | Abnormality of serum amino acid levels (HP:0003112) | 2.33844361 |
| 76 | Nausea (HP:0002018) | 2.32603692 |
| 77 | Dicarboxylic aciduria (HP:0003215) | 2.31857725 |
| 78 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.31857725 |
| 79 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.29598550 |
| 80 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.29598550 |
| 81 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.22182344 |
| 82 | Mitral stenosis (HP:0001718) | 2.21978103 |
| 83 | Alkalosis (HP:0001948) | 2.19486297 |
| 84 | Hypoglycemic seizures (HP:0002173) | 2.18121697 |
| 85 | Sensorimotor neuropathy (HP:0007141) | 2.17827534 |
| 86 | Menorrhagia (HP:0000132) | 2.15765692 |
| 87 | Hemorrhage of the eye (HP:0011885) | 2.15538968 |
| 88 | Proximal tubulopathy (HP:0000114) | 2.12523734 |
| 89 | Abnormal ciliary motility (HP:0012262) | 2.11090606 |
| 90 | Abnormal cartilage morphology (HP:0002763) | 2.10593532 |
| 91 | Abnormality of iron homeostasis (HP:0011031) | 2.09303137 |
| 92 | Abnormal gallbladder morphology (HP:0012437) | 2.07293698 |
| 93 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.06657354 |
| 94 | Increased purine levels (HP:0004368) | 2.06099086 |
| 95 | Hyperuricemia (HP:0002149) | 2.06099086 |
| 96 | Vomiting (HP:0002013) | 2.05939954 |
| 97 | Cholelithiasis (HP:0001081) | 2.05374010 |
| 98 | Reduced antithrombin III activity (HP:0001976) | 2.04548278 |
| 99 | Pancreatitis (HP:0001733) | 2.04518608 |
| 100 | Cerebral edema (HP:0002181) | 2.02947194 |
| 101 | Late onset (HP:0003584) | 2.02099723 |
| 102 | Neonatal onset (HP:0003623) | 2.01979780 |
| 103 | Acanthocytosis (HP:0001927) | 2.01971714 |
| 104 | Abnormality of urine glucose concentration (HP:0011016) | 2.01824302 |
| 105 | Glycosuria (HP:0003076) | 2.01824302 |
| 106 | Mucopolysacchariduria (HP:0008155) | 2.01779249 |
| 107 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.01779249 |
| 108 | Osteomalacia (HP:0002749) | 2.01420619 |
| 109 | Rickets (HP:0002748) | 2.01406288 |
| 110 | Cortical dysplasia (HP:0002539) | 2.01205390 |
| 111 | Nephritis (HP:0000123) | 2.01156911 |
| 112 | Amyloidosis (HP:0011034) | 2.01006798 |
| 113 | Abnormality of vitamin metabolism (HP:0100508) | 1.99013412 |
| 114 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.98802721 |
| 115 | Abnormality of carpal bone ossification (HP:0006257) | 1.96581650 |
| 116 | Absent/shortened dynein arms (HP:0200106) | 1.95139274 |
| 117 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.95139274 |
| 118 | Premature rupture of membranes (HP:0001788) | 1.93265349 |
| 119 | Hypochromic microcytic anemia (HP:0004840) | 1.93067747 |
| 120 | Thrombophlebitis (HP:0004418) | 1.91915529 |
| 121 | Metaphyseal irregularity (HP:0003025) | 1.91774288 |
| 122 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.89248820 |
| 123 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.87013968 |
| 124 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.87013968 |
| 125 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.87013968 |
| 126 | Ileus (HP:0002595) | 1.86634287 |
| 127 | Opisthotonus (HP:0002179) | 1.85727849 |
| 128 | Hypophosphatemic rickets (HP:0004912) | 1.85123697 |
| 129 | Gingival bleeding (HP:0000225) | 1.83363077 |
| 130 | Elevated alkaline phosphatase (HP:0003155) | 1.81573164 |
| 131 | Patchy hypopigmentation of hair (HP:0011365) | 1.78424057 |
| 132 | Axonal loss (HP:0003447) | 1.77977409 |
| 133 | Enlarged kidneys (HP:0000105) | 1.77603608 |
| 134 | Tetraparesis (HP:0002273) | 1.76504801 |
| 135 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.76258076 |
| 136 | Polycythemia (HP:0001901) | 1.75813840 |
| 137 | Beaking of vertebral bodies (HP:0004568) | 1.75498568 |
| 138 | Abnormality of the gallbladder (HP:0005264) | 1.75398654 |
| 139 | Symptomatic seizures (HP:0011145) | 1.71846719 |
| 140 | Abnormal tarsal ossification (HP:0008369) | 1.70880860 |
| 141 | Dysostosis multiplex (HP:0000943) | 1.70133774 |
| 142 | Protuberant abdomen (HP:0001538) | 1.68688509 |
| 143 | Megaloblastic anemia (HP:0001889) | 1.68130350 |
| 144 | Bifid scrotum (HP:0000048) | 1.66099969 |
| 145 | Poor head control (HP:0002421) | 1.65529231 |
| 146 | Right ventricular cardiomyopathy (HP:0011663) | 1.59727976 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK19 | 7.09909670 |
| 2 | ERN1 | 4.25727074 |
| 3 | MAP3K10 | 3.88901014 |
| 4 | BCKDK | 3.87903061 |
| 5 | EIF2AK1 | 3.82708475 |
| 6 | TTK | 2.92607714 |
| 7 | FGFR4 | 2.92337370 |
| 8 | EIF2AK3 | 2.87816022 |
| 9 | NEK1 | 2.65049003 |
| 10 | SIK1 | 2.64142523 |
| 11 | TAOK3 | 2.33984705 |
| 12 | TSSK6 | 2.27246969 |
| 13 | MST1R | 2.23654230 |
| 14 | MAP2K3 | 2.20039187 |
| 15 | LMTK2 | 2.03190916 |
| 16 | EPHB2 | 1.98185019 |
| 17 | LATS1 | 1.92050734 |
| 18 | FRK | 1.75058505 |
| 19 | WEE1 | 1.75039302 |
| 20 | ERBB4 | 1.72796141 |
| 21 | SRPK1 | 1.65335731 |
| 22 | KDR | 1.65076316 |
| 23 | EPHA3 | 1.62404065 |
| 24 | BUB1 | 1.61451165 |
| 25 | MAP3K3 | 1.57625728 |
| 26 | PTK6 | 1.51692243 |
| 27 | TYK2 | 1.50559994 |
| 28 | TRIB3 | 1.47781411 |
| 29 | PKN2 | 1.46101492 |
| 30 | NEK9 | 1.45523501 |
| 31 | INSRR | 1.44541704 |
| 32 | STK39 | 1.39011355 |
| 33 | FLT3 | 1.38063347 |
| 34 | NME2 | 1.33744419 |
| 35 | TBK1 | 1.33632596 |
| 36 | MET | 1.31300324 |
| 37 | PLK3 | 1.29822333 |
| 38 | ACVR1B | 1.27360825 |
| 39 | MAP3K14 | 1.20980068 |
| 40 | RIPK1 | 1.18362422 |
| 41 | ABL2 | 1.17235671 |
| 42 | PIK3CG | 1.16908013 |
| 43 | IRAK3 | 1.13874087 |
| 44 | PDGFRA | 1.12978059 |
| 45 | MAP2K4 | 1.07577159 |
| 46 | EEF2K | 1.05814293 |
| 47 | STK24 | 1.05463782 |
| 48 | ERBB2 | 1.00484620 |
| 49 | GRK1 | 0.99151474 |
| 50 | MAPK11 | 0.98272905 |
| 51 | TAF1 | 0.94962967 |
| 52 | STK16 | 0.92962627 |
| 53 | CAMK1G | 0.92448481 |
| 54 | SCYL2 | 0.92432486 |
| 55 | PLK4 | 0.91823326 |
| 56 | STK4 | 0.91498856 |
| 57 | TGFBR2 | 0.88136762 |
| 58 | LRRK2 | 0.88075390 |
| 59 | STK38L | 0.87537120 |
| 60 | EPHA2 | 0.87258625 |
| 61 | PRKG2 | 0.86678248 |
| 62 | CDK6 | 0.85848938 |
| 63 | FGFR1 | 0.85405445 |
| 64 | DDR2 | 0.83799202 |
| 65 | NME1 | 0.83414149 |
| 66 | IRAK1 | 0.82365354 |
| 67 | MKNK1 | 0.82120923 |
| 68 | STK10 | 0.81513827 |
| 69 | EPHB1 | 0.81262824 |
| 70 | MAP2K6 | 0.81249746 |
| 71 | PBK | 0.80971914 |
| 72 | PLK1 | 0.80781971 |
| 73 | SMG1 | 0.80475025 |
| 74 | JAK2 | 0.79915017 |
| 75 | ICK | 0.79579941 |
| 76 | MAP3K12 | 0.77679004 |
| 77 | PNCK | 0.76531238 |
| 78 | MKNK2 | 0.76026555 |
| 79 | PRKAA2 | 0.75047280 |
| 80 | CDK7 | 0.74096604 |
| 81 | MAP3K8 | 0.73778224 |
| 82 | MATK | 0.73238027 |
| 83 | MAP2K1 | 0.72618770 |
| 84 | BMPR1B | 0.70305483 |
| 85 | JAK1 | 0.68668635 |
| 86 | MAPK12 | 0.68233181 |
| 87 | BRSK1 | 0.68086406 |
| 88 | TRIM28 | 0.67977534 |
| 89 | TIE1 | 0.66426368 |
| 90 | GRK7 | 0.65994101 |
| 91 | MAPK4 | 0.63511781 |
| 92 | NEK2 | 0.62936237 |
| 93 | WNK4 | 0.62473480 |
| 94 | PLK2 | 0.60803379 |
| 95 | ALK | 0.60179438 |
| 96 | MAPKAPK3 | 0.59987180 |
| 97 | CDC7 | 0.59039191 |
| 98 | GSK3A | 0.58255860 |
| 99 | PTK2 | 0.57393351 |
| 100 | CSK | 0.56807874 |
| 101 | NEK6 | 0.56736790 |
| 102 | YES1 | 0.55431644 |
| 103 | MST4 | 0.55222464 |
| 104 | MELK | 0.54566019 |
| 105 | MYLK | 0.53943584 |
| 106 | MAP3K2 | 0.53808688 |
| 107 | TLK1 | 0.53194048 |
| 108 | ZAP70 | 0.51280784 |
| 109 | STK3 | 0.50966663 |
| 110 | CHUK | 0.50897731 |
| 111 | FGFR2 | 0.50414255 |
| 112 | PAK2 | 0.49934406 |
| 113 | TGFBR1 | 0.49822596 |
| 114 | PIM2 | 0.48093979 |
| 115 | VRK2 | 0.48040942 |
| 116 | CDK12 | 0.47975586 |
| 117 | IKBKE | 0.47684622 |
| 118 | PRKACG | 0.47223914 |
| 119 | WNK3 | 0.46076908 |
| 120 | BRSK2 | 0.45476096 |
| 121 | CSNK1E | 0.45241065 |
| 122 | IGF1R | 0.45166217 |
| 123 | CHEK2 | 0.44028006 |
| 124 | CDK4 | 0.43585212 |
| 125 | DYRK1B | 0.42784575 |
| 126 | TESK1 | 0.42733328 |
| 127 | BMX | 0.42556686 |
| 128 | GRK6 | 0.42225275 |
| 129 | MAP3K11 | 0.41235529 |
| 130 | AURKB | 0.40864172 |
| 131 | FGFR3 | 0.40827912 |
| 132 | EIF2AK2 | 0.40538553 |
| 133 | MAP3K9 | 0.40271330 |
| 134 | EGFR | 0.39649815 |
| 135 | CSNK2A1 | 0.39472571 |
| 136 | PDK2 | 0.39345362 |
| 137 | CSNK1G1 | 0.38393805 |
| 138 | BLK | 0.37570662 |
| 139 | NTRK1 | 0.36603278 |
| 140 | MAP2K2 | 0.35596166 |
| 141 | AKT3 | 0.35310545 |
| 142 | IKBKB | 0.34662784 |
| 143 | OXSR1 | 0.34429129 |
| 144 | AKT2 | 0.34169871 |
| 145 | PAK4 | 0.33973092 |
| 146 | PRKCZ | 0.32471915 |
| 147 | NUAK1 | 0.32065720 |
| 148 | PRKAA1 | 0.31859745 |
| 149 | FER | 0.31733406 |
| 150 | ATM | 0.31269447 |
| 151 | CSNK1G3 | 0.30530727 |
| 152 | CSF1R | 0.28902615 |
| 153 | CAMK1D | 0.26989795 |
| 154 | LATS2 | 0.26930559 |
| 155 | MAPK15 | 0.26272199 |
| 156 | MTOR | 0.25053447 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.92107137 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.51846793 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.86676415 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.70431844 |
| 5 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.69077409 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.65102995 |
| 7 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.62966014 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.56262794 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.45065878 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.39891952 |
| 11 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.38511466 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.38173775 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.32178861 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.25433815 |
| 15 | Histidine metabolism_Homo sapiens_hsa00340 | 2.12060960 |
| 16 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.06570638 |
| 17 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.05755170 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 2.00958780 |
| 19 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.93942629 |
| 20 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.93325099 |
| 21 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.92288175 |
| 22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.90474621 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.89523239 |
| 24 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.86606929 |
| 25 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.81254743 |
| 26 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.80874280 |
| 27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.79387502 |
| 28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.75535308 |
| 29 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.69734458 |
| 30 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.68433569 |
| 31 | Retinol metabolism_Homo sapiens_hsa00830 | 1.65280650 |
| 32 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.61187388 |
| 33 | Bile secretion_Homo sapiens_hsa04976 | 1.55746464 |
| 34 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.48393259 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.45353881 |
| 36 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.43741413 |
| 37 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.41080104 |
| 38 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.36141123 |
| 39 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.35383106 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.29338134 |
| 41 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.29031070 |
| 42 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.27996803 |
| 43 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.27787999 |
| 44 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.27565769 |
| 45 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.19454197 |
| 46 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.16343806 |
| 47 | Carbon metabolism_Homo sapiens_hsa01200 | 1.10772528 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 1.09703874 |
| 49 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.09111347 |
| 50 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.08600569 |
| 51 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.07548178 |
| 52 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.04553491 |
| 53 | Proteasome_Homo sapiens_hsa03050 | 1.03414822 |
| 54 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.02721219 |
| 55 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.00758165 |
| 56 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.99223978 |
| 57 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.98629274 |
| 58 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.97242819 |
| 59 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.96537356 |
| 60 | Sulfur relay system_Homo sapiens_hsa04122 | 0.95489868 |
| 61 | Protein export_Homo sapiens_hsa03060 | 0.88190355 |
| 62 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.84746489 |
| 63 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.82764984 |
| 64 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.82160689 |
| 65 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.78254897 |
| 66 | Lysine degradation_Homo sapiens_hsa00310 | 0.70826015 |
| 67 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68988652 |
| 68 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.68422686 |
| 69 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.67373201 |
| 70 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.66287181 |
| 71 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.65822630 |
| 72 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.64484464 |
| 73 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.63867161 |
| 74 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.59003703 |
| 75 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.55286619 |
| 76 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.52352001 |
| 77 | Galactose metabolism_Homo sapiens_hsa00052 | 0.52279443 |
| 78 | Mismatch repair_Homo sapiens_hsa03430 | 0.47003419 |
| 79 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.46817356 |
| 80 | Metabolic pathways_Homo sapiens_hsa01100 | 0.43662411 |
| 81 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.42617060 |
| 82 | * Mineral absorption_Homo sapiens_hsa04978 | 0.34401632 |
| 83 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.33481354 |
| 84 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.31172964 |
| 85 | Prion diseases_Homo sapiens_hsa05020 | 0.30213039 |
| 86 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.30162988 |
| 87 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.27555846 |
| 88 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.26248758 |
| 89 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.26152340 |
| 90 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.25545646 |
| 91 | RNA transport_Homo sapiens_hsa03013 | 0.25305606 |
| 92 | Insulin resistance_Homo sapiens_hsa04931 | 0.24576075 |
| 93 | DNA replication_Homo sapiens_hsa03030 | 0.24230951 |
| 94 | RNA polymerase_Homo sapiens_hsa03020 | 0.23330588 |
| 95 | Thyroid cancer_Homo sapiens_hsa05216 | 0.22159482 |
| 96 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.19864521 |
| 97 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.19790940 |
| 98 | Adherens junction_Homo sapiens_hsa04520 | 0.18257126 |
| 99 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.17440901 |
| 100 | Legionellosis_Homo sapiens_hsa05134 | 0.17185581 |
| 101 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.17059288 |
| 102 | Lysosome_Homo sapiens_hsa04142 | 0.13106228 |
| 103 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.11495254 |
| 104 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.08790475 |
| 105 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.08120198 |
| 106 | Pertussis_Homo sapiens_hsa05133 | 0.07198939 |
| 107 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.06602743 |
| 108 | Malaria_Homo sapiens_hsa05144 | 0.04711605 |
| 109 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.04340464 |
| 110 | Hepatitis C_Homo sapiens_hsa05160 | 0.03497467 |
| 111 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.02056535 |
| 112 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1017941 |
| 113 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0755368 |
| 114 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0659864 |
| 115 | Leishmaniasis_Homo sapiens_hsa05140 | -0.0643610 |
| 116 | Graft-versus-host disease_Homo sapiens_hsa05332 | -0.0410507 |
| 117 | Amoebiasis_Homo sapiens_hsa05146 | -0.0283348 |
| 118 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.0228821 |
| 119 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | -0.0219869 |
| 120 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0198123 |
| 121 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0184353 |

